News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Leiner Health Products Inc. Announces The Introduction Of Famotidine 20 Mg Tablets (Compare To The Active Ingredient In Maximum Strength Pepcid(R) AC



9/27/2006 12:25:49 PM

CARSON, Calif.--(BUSINESS WIRE)--Leiner Health Products, LLC announced today that its development partner Dr. Reddy’s Laboratories, Inc. (NYSE: RDY) has received FDA approval of its Abbreviated New Drug Application (ANDA) for the over-the-counter (OTC) version of Famotidine 20 mg. Marketing exclusivity for the brand (Maximum Strength Pepcid®* AC) ended on September 23, 2006, opening the door for 95 million acid indigestion and heartburn sufferers to get relief at store brand prices.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES